Galera Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Galera Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014181
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Galera Therapeutics Inc (Galera Therapeutics) is a clinical stage biotechnology company that discovers and develops novel cancer treatments. The company also concentrates on the prevention of radiation-induced toxicity including mucositis and the treatment of cancer. Its GC4419 is a selective small molecule superoxide dismutase enzyme mimetic that quickly converts superoxide free radical molecules to hydrogen peroxide and oxygen. Galera Therapeutic’s dismutase mimetics copies the human superoxide dismutase enzyme activities and overcome the deficiency. The company’s research and development unit concentrates on protection from normal tissue damage and direct anti-cancer therapy. Galera Therapeutics is headquartered in Malvern, Pennsylvania, the US.

Galera Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Galera Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Galera Therapeutics Raises Additional USD15 Million in Series B Financing 10
Galera Therapeutics Raises Additional USD5 Million in Series B Financing 11
Galera Therapeutics Raises USD37 Million in Series B Financing 12
Galera Therapeutics Raises USD4.74 Million In Venture Financing 13
Galera Therapeutics Raises US$11 Million In Series A Financing 14
Galera Therapeutics Raises US$0.4 Million In Venture Financing 15
Galera Therapeutics Raises US$0.8 Million In Series 1 Financing 16
Galera Therapeutics Inc – Key Competitors 17
Galera Therapeutics Inc – Key Employees 18
Galera Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Galera Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Galera Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Galera Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Galera Therapeutics Raises Additional USD15 Million in Series B Financing 10
Galera Therapeutics Raises Additional USD5 Million in Series B Financing 11
Galera Therapeutics Raises USD37 Million in Series B Financing 12
Galera Therapeutics Raises USD4.74 Million In Venture Financing 13
Galera Therapeutics Raises US$11 Million In Series A Financing 14
Galera Therapeutics Raises US$0.4 Million In Venture Financing 15
Galera Therapeutics Raises US$0.8 Million In Series 1 Financing 16
Galera Therapeutics Inc, Key Competitors 17
Galera Therapeutics Inc, Key Employees 18

★海外企業調査レポート[Galera Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Studsvik AB (SVIK):電力:M&Aディール及び事業提携情報
    Summary Studsvik AB (Studsvik) is a nuclear services company. It develops and delivers technical solutions to improve reactor performance, and reduce risks and costs across the nuclear and radioactive material lifecycle. The company offers fuel and reactor management software; advanced engineering a …
  • NeoDynamics AB:製品パイプライン分析
    Summary NeoDynamics AB (NeoDynamics) is an independent medical technology company that focuses on the development of medical solutions for the quick detection and treatment of cancer. It is developing the NeoNavia biopsy system that helps collect samples from breast lesions or axillary lymph nodes f …
  • Berkeley Energia Ltd:企業の戦略・SWOT・財務分析
    Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report Summary Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Brasfield & Gorrie LLC:企業の戦略・SWOT・財務分析
    Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report Summary Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Landesbank Berlin Holding Ag
    Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report Summary Landesbank Berlin Holding Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Baker Hughes, a GE Co LLC (BHGE):企業の財務・戦略的SWOT分析
    Baker Hughes, a GE Co LLC (BHGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • BioDot Inc-医療機器分野:企業M&A・提携分析
    Summary BioDot Inc (BioDot) is a healthcare products provider that manufactures low volumes of fluids and powder dispensing products. The company offers lateral flow, immunoblots, biojet, airjet, dry chemistry, bio chips, low volume PCR, glucose biosensors, biosensors, polyject and dispo powder disp …
  • St. George’s University of London:製薬・医療:M&Aディール及び事業提携情報
    Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider. It offers undergraduate and post graduate courses. The university’s undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthca …
  • Castle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Castle Biosciences Inc (Castle Biosciences) is a drug development company that develops and commercializes diagnostic and prognostic tests for cancers. The company offers tests for cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its DecisionDx-melanoma identifies stage I or I …
  • Hdfc Bank Ltd
    Hdfc Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hdfc Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Filtronic plc:企業の戦略・SWOT・財務分析
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Organo Corporation:企業の戦略・SWOT・財務情報
    Organo Corporation - Strategy, SWOT and Corporate Finance Report Summary Organo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Essential Energy Services Ltd (ESN):企業の財務・戦略的SWOT分析
    Summary Essential Energy Services Ltd (Essential Energy) operates as an oil and gas company that offers oilfield services. The company provides coil well services and tool services. Its services include coil tubing, fluid and nitrogen pumping, completion, abandonment, and downhole tools and equipmen …
  • Purdue Pharma LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …
  • Energisa SA (ENGI11):電力:M&Aディール及び事業提携情報
    Summary Energisa SA (Energisa) is a power utility that generates, distributes and sells electricity. The company generates electricity through wind, small hydropower, and biomass resources. It also operates and maintains hydroelectric power plants for other companies; constructs and refurbishes gene …
  • Guernsey Electricity Limited:発電所・企業SWOT分析
    Guernsey Electricity Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Special Metals Corp:企業の戦略・SWOT・財務分析
    Special Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Special Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Avid Technology Inc (AVID):企業の財務・戦略的SWOT分析
    Avid Technology Inc (AVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Grant Thornton International Ltd.:戦略・SWOT・企業財務分析
    Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆